30th week of 2012 patent applcation highlights part 36 |
Patent application number | Title | Published |
20120189490 | CLEANSING SYSTEM USING OZONE AND NEBULIZED FLUIDS - A process is described for cleansing and deodorizing an environmental space including deodorizing a space with an ozone treatment for a pre-selected time; and thereafter, automatically and without human intervention, exposing the space to a nebulized liquid, having ozone quenching properties and comprising an odor neutralizing or air freshening agent, to reduce ozone levels to a level safe for human exposure and to remove residual odors. An apparatus for carrying out the process and compositions for use in the process are further disclosed. | 2012-07-26 |
20120189491 | ROBOTIC POOL CLEANER WITH INTERNAL ULTRAVIOLET WATER STERILIZATION - A pool cleaning apparatus for cleaning the bottom and sidewalls of a swimming pool has an exterior housing through which water is circulated and at least one source of water-sterilizing ultraviolet (UV) radiation in the form of a straight, circular and/or curvilinear tube that is positioned on the interior of the housing so that the amount of any bacteria in the water circulated past the UV radiation source is reduced. | 2012-07-26 |
20120189492 | FULLERENE COMPOSITIONS AND METHODS FOR PHOTOCHEMICAL PURIFICATION - In various embodiments, the present disclosure describes fullerene derivatives that are capable of photocatalytically generating reactive oxygen species in the presence of ultraviolet and/or visible light. In some embodiments, the fullerene derivatives are aminofullerenes containing a plurality of amine-terminated moieties covalently bonded to the fullerene cage. The fullerene derivatives may optionally be covalently bonded to a substrate surface for use in photocatalytic disinfection systems for removing various contaminants including, for example, bacteria, viruses, protozoa and chemical pollutants. Methods using the present fullerene and aminofullerene derivatives in various purification processes are also described herein. | 2012-07-26 |
20120189493 | ANTI-MICROBIAL SYSTEMS AND METHODS - An antimicrobial system. When generally formulated to disinfect a catheter, the antimicrobial substance comprises water and between approximately 10 and 200 mg of tetrasodium EDTA for each milliliter of water. When formulated as a treatment solution for treating an infected catheter, the antimicrobial substance comprises water and between approximately 5 and 80 mg of tetrasodium EDTA for each milliliter of water. When formulated as a prophylactic substance for inhibiting infection of a catheter, the antimicrobial substance comprises water and between approximately 5 and 40 mg of tetrasodium EDTA for each milliliter of water. | 2012-07-26 |
20120189494 | Peracetic Acid Vapor Sterilization of Food and Beverage Containers - The present invention is directed to a method of sterilizing a surface comprising treating such surface with a vapor comprising peracetic acid at a concentration of at least about 3500 ppm at between about 57° and about 75° C. Such method is preferably conducted in the absence of a hydrogen peroxide initiator, and is particularly suitable for the sterilization of polyethylene terephthalate bottles. | 2012-07-26 |
20120189495 | PROCESS FOR STERILIZING AN ARTICLE - A composition is disclosed which comprises (A) an anti-microbial agent comprising peracetic acid; and (B) a reagent mixture comprising a buffer, an anticorrosive agent and a chelator. The composition may be characterized by the absence of molybdate. The foregoing composition may be dispersed in water to form a liquid sterilant. The liquid sterilant may be used for sterilizing articles such as medical, dental, pharmaceutical, veterinary or mortuary instruments, devices, and the like. | 2012-07-26 |
20120189496 | SPREADING LAYER AND METHOD FOR PRODUCING AN ANALYSIS ELEMENT SPREADING LAYER - Methods of producing an analysis spreading layer for absorbing a liquid to be analyzed, by: supplying a porous membrane having a bottom, a top and a thickness D, the size of the pores of the membrane increasing over its thickness D; cutting the membrane at a predefined distance, the spreading layer being a sublayer with a thickness d less than the starting thickness D, the pores of the spreading layer having a fluid connection to one another in such a manner that it is permeable to a liquid. The membrane surface is formed by removing a sublayer of the membrane being the liquid outlet side of the spreading layer. The mean size of the pores on the liquid outlet side is at least 1 μm. | 2012-07-26 |
20120189497 | SYSTEM AND METHOD FOR REPOSITIONING A DIAGNOSTIC TEST STRIP AFTER INOCULATION - A system for analyzing the concentration of an analyte in a fluid sample comprises a test strip and a meter. The test strip is capable of being inoculated by the fluid sample. The test strip includes a test element, which contains at least one reagent adapted to cause a reaction when brought into contact with the analyte. The meter includes a read-head, a repositioning device, and a display. The read-head is capable of producing a signal indicative of the reaction between the analyte and the at least one reagent. The display is capable of displaying the analyte concentration. The repositioning device is adapted to move the test strip from a loading position to a testing position. The testing position positions the test element proximate to the read-head. | 2012-07-26 |
20120189498 | System for Making Renewable Fuels - Multiple catalytic processing stations couple with a system which produces volatile gas streams from biomass decomposition at discrete increasing temperatures. These catalytic processing stations can be programmed to maximize conversion of biomass to useful renewable fuel components based on input feedstock and desired outputs. | 2012-07-26 |
20120189499 | GASIFICATION REACTOR FOR PRODUCTION OF CRUDE GAS CONTAINING CO OR H2 - In the case of a gasification reactor for the production of crude gas, containing CO or H | 2012-07-26 |
20120189500 | Large Scale Energy Efficient CO2 Sequestration and Processing - A system for treating an exhaust stream issued by a power plant processes the exhaust stream in a methanol reactor. The exhaust stream contains CO and/or CO | 2012-07-26 |
20120189501 | PRODUCTION OF POLYCRYSTALLINE SILICON IN SUBSTANTIALLY CLOSED-LOOP SYSTEMS THAT INVOLVE DISPROPORTIONATION OPERATIONS - Production of polycrystalline silicon in substantially closed-loop processes and systems is disclosed. The processes and systems generally involve disproportionation of trichlorosilane to produce silane or dichlorosilane and thermal decomposition of silane or dichlorosilane to produce polycrystalline silicon. | 2012-07-26 |
20120189502 | BOTTOM-LOADING WATER COOLERS WITH OZONE STERILIZING DEVICES - Devices and methods for sterilizing bottled water coolers (and water dispensed from such coolers) are disclosed. More specifically, a bottled water cooler is disclosed that includes a water bottle, a cabinet, a cold tank, a bottle receptacle located in the bottom half of the cabinet that is configured to receive the water bottle, and an ozone generator. The ozone generator is capable of dispensing ozone gas within the water bottle and/or cold tank, such that the ozone gas will be effective to sterilize the interior portions of the water bottle and/or cold tank (and the water contained therein). | 2012-07-26 |
20120189503 | EXHAUST-GAS PURIFICATION CATALYTIC SYSTEM - A Rh-including catalyst layer of an upstream catalyst | 2012-07-26 |
20120189504 | OZONE GAS GENERATOR AND METHOD FOR MANUFACTURING THE SAME - A dielectric | 2012-07-26 |
20120189505 | PRESSURE CASCADED TWO-STAGE HYDROCRACKING UNIT - An apparatus for hydrocracking an oil feedstock to produce a light oil stream without build-up of heavy polynuclear aromatic (HPNA) hydrocarbons in the recycle stream is provided. The apparatus includes a reactor for hydroprocessing the hydrocarbon feedstock to produce effluents, which are subsequently fractionated. Additional hydroprocessing reactors are provided for hydroprocessing individual fractionated product streams. | 2012-07-26 |
20120189506 | Detergent Delivery Device - The invention relates to a multi-dosing detergent delivery device. In embodiments of the present invention, the multi-dosing detergent delivery device comprises: a housing comprising a base and a lid; a refill holder and shaft located within the housing and arranged, in use, for receiving thereon a cartridge having a plurality X of chambers each accommodating a detergent composition; a directing means formed in the lid of said device to direct, in use, wash liquor collected on said lid selectively into a chamber of the cartridge to contact the detergent composition therein; an outlet formed in a base region of said housing to allow, in use, detergent loaded wash liquor to exit the device; and indexing means located within the shaft of the device for causing, in use, automatic movement of said cartridge relative to said housing during and subsequent to a wash cycle so as to cause a neighbouring chamber to be in an exposed, ready to be used, position prior to a next washing cycle, said indexing means comprising: a thermally reactive element, a resilient biasing means, a gearing mechanism and a clutch element for selectively decoupling torque forces generated by expansion of said thermally reactive element from said shaft. | 2012-07-26 |
20120189507 | MODULAR AUTOMATIC TRAVELING APPARATUS - A modular automatic traveling apparatus includes a seat and an external coupling device mounted onto the seat. The seat includes a moving device to allow the seat to move automatically and an assembling passage which has two ends formed respectively an inlet and a holding orifice. The holding orifice has a detent portion on the perimeter thereof. The external coupling device has an installation portion which is inserted into the assembling passage through the inlet and latched on the detent portion and anchored on the holding orifice, thus is movable automatically with the seat. Users can change the external coupling devices with varying functions such as a vacuum cleaner, odorator and the like to automatically perform different types of tasks through the automatic movement of the seat. | 2012-07-26 |
20120189508 | STERILIZATION CONTAINER WITH FILTER UNIT - A sterilization container has a box-like lower part and a removable container cover ( | 2012-07-26 |
20120189509 | AUTOMATIC ANALYZING METHOD AND SYSTEM FOR TEST STRIPS - An automatic analyzing method for test strips includes steps of: providing a test strip unit at least having a reacting region and an image calibration region; capturing an image of the test strip unit; analyzing the image so as to obtain a first image signal of an image calibration region and a second image signal of a reacting region; comparing the first image signal with a standard signal so as to obtain image signal calibration parameters; calibrating the second image signal by applying the image signal calibration parameters so as to obtain a third image signal; and comparing the third image signal with data in a database so as to obtain a corresponding parameter values. The present invention also provides an automatic analyzing method for test strips. | 2012-07-26 |
20120189510 | CUVETTE - An exemplary embodiment of the present invention relates to a cuvette of which an inner space thereof is easily cleansed while minimizing its inner space. | 2012-07-26 |
20120189511 | Micro-Reactor System Assembly - A micro-reactor system assembly comprises a stack of at least n process modules ( | 2012-07-26 |
20120189512 | METHOD FOR CONTINUOUS MAGNETIC ORE SEPARATION AND/OR DRESSING AND RELATED SYSTEM - A method for magnetic ore separation and/or dressing is provided, in which metalliferous recoverable materials are separated from conveyed metalliferous ore rock. The method may include producing a pulp including metalliferous recoverable material, executing a hydrophobizing reaction of recoverable material in the pulp, synthesizing a hydrophobized, magnetizable material in liquid suspension and adding this suspension to the pulp, causing an agglomeration reaction between hydrophobized magnetizable material and hydrophobized recoverable material to form magnetizable agglomerates in the pulp, separating the magnetizable agglomerates from the pulp, mixing separation products containing the agglomerates with a non-polar liquid insoluble in water and decomposing the agglomerates in the non-polar liquid into magnetizable material and recoverable material, separating the magnetizable material from the recoverable material, and removing moisture from the separation portion containing the recoverable material of the second separation stage to synthesize the recoverable material. | 2012-07-26 |
20120189513 | IONIC IMPURITIES REJECTION AND CHROMATOGRAPHIC PURIFICATION USING ION EXCHANGE - The invention covers the combination of utilizing the selectivity of an adsorbent to remove species from a liquid containing mixtures of ions and then subjecting the loaded resin to a chromatographic displacement utilizing the most selectively adsorbed species to displace the undesired co-adsorbing impurities. The technique can be used even when the most selectively adsorbed species is present as a minor constituent in the feed solution. | 2012-07-26 |
20120189514 | IONIC IMPURITIES REJECTION AND CHROMATOGRAPHIC PURIFICATION USING ION EXCHANGE - The invention covers the combination of utilizing the selectivity of an adsorbent to remove species from a liquid containing mixtures of ions and then subjecting the loaded resin to a chromatographic displacement utilizing the most selectively adsorbed species to displace the undesired co-adsorbing impurities. The technique can be used even when the most selectively adsorbed species is present as a minor constituent in the feed solution. | 2012-07-26 |
20120189515 | PRODUCTION OF CALCIUM CARBONATE - A method of producing calcium carbonate from lime comprises the steps of: (i) providing an aqueous solution comprising 10% to 35% by weight of dissolved polyhydroxy compound and 1% to 5% by weight of dissolved calcium hydroxide (expressed as Ca(OH) | 2012-07-26 |
20120189516 | PRODUCTION OF HIGH PURITY LITHIUM COMPOUNDS DIRECTLY FROM LITHIUM CONTAINING BRINES - A process for reducing the amount of magnesium in a lithium-containing brine by adding an aqueous solution of KCl to the brine to precipitate at least some of the magnesium as carnallite salt is disclosed. Lithium salts prepared using this magnesium removal process are also disclosed. | 2012-07-26 |
20120189517 | COMPOSITION COMPRISING CERIUM OXIDE AND ZIRCONIUM OXIDE HAVING A SPECIFIC POROSITY, PREPARATION METHOD THEREOF AND USE OF SAME IN CATALYSIS - A composition including cerium and zirconium oxides, including at least 30 wt.-% cerium oxide is desired. Following calcination at a temperature of 900 DEG C. for 4 hours, the composition has two populations of pores, the diameters of the first population being centered around a value of between 5 nm and 15 nm for a composition including 30% to 65% cerium oxide or between 10 nm and 20 nm for more than 65% cerium oxide and the diameter of the second population being centered around a value of between 45 nm and 65 nm for 30% to 65% cerium oxide or between 60 nm and 100 nm for more than 65% cerium oxide. | 2012-07-26 |
20120189518 | DISORDERED MOLECULAR SIEVE SUPPORTS FOR THE SELECTIVE CATALYTIC REDUCTION OF NOx - A catalyst for selective catalytic reduction of NO | 2012-07-26 |
20120189519 | Flue-gas purification and reclamation system and method thereof - A flue-gas purification system includes a flue-gas cycling system, a reactor, and an absorbent adding system having at least a catalytic absorbent, wherein the catalytic absorbent is being gasified for reacting with the flue-gas in the reactor in a homogenous gas-gas phase reacting manner. Therefore, the purification system has fast reaction rate between the pollutants of the flue-gas and the catalytic absorbent, which is preferably ammonia, to efficiently remove pollutants, so as to effectively purify the flue-gas. | 2012-07-26 |
20120189520 | Activation of Reactive Compound with Catalyst - Concentrated aqueous hydrogen peroxide or another reactive compound in a liquid carrier is activated by atomization and contact with a suitable catalyst that is concurrently atomized in a carrier liquid. Concentrated hydrogen peroxide and a hydrogen peroxide activation catalyst are atomized into a droplet spray for catalytic activation of the hydrogen peroxide in this invention, useful for treatment of a combustion flue gas containing contaminants such as NO | 2012-07-26 |
20120189521 | AIR POLLUTION CONTROL DEVICE AND METHOD FOR REDUCING AMOUNT OF MERCURY IN FLUE GAS - The air pollution control device includes: NH | 2012-07-26 |
20120189522 | Method of Desulfurizing Flue Gas, an Arrangement for Desulfurizing Flue Gas, and a Method of Modernizing a Desulfurization Arrangement - A method of desulfurizing flue gas in connection with oxy-combustion. A sulfur containing gas flow is introduced to a flue gas desulfurization arrangement having a spray tower at its top part and a reaction tank at its bottom part, in which the reaction tank contains liquid slurry having a surface level L. Sorbent-containing liquid slurry is sprayed to the sulfur containing gas flow. Sulfur-containing molecules are allowed to be absorbed into liquid slurry droplets. The liquid slurry droplets are allowed to enter the liquid slurry in the reaction tank. Oxygen containing gas is bubbled in the liquid slurry from a gas inlet header and nozzles in the reaction tank, in which the nozzles are arranged at a certain level in the reaction tank. Sulfur-containing particulates settle in the reaction tank. The sulfur-containing particulates are removed as a slurry from the reaction tank, and the bubbled gas that has left the liquid slurry is discharged separately from the flue gas from the flue gas desulfurization arrangement. | 2012-07-26 |
20120189523 | Method and Apparatus for Removing Low-Concentration Methane - Disclosed are a method and an apparatus for removing methane from a gas which contains the methane at such a low concentration as not to be rendered into a combustible range with whatever ratio of air mixed therewith. In order to ensure satisfactory methane removal performance even in the coexistence of sulfur compound and in order also to provide stable methane removal performance for an extended period of time without performance deterioration even when the methane concentration varies significantly, the gas is fed to a heat exchanger for preheating and methane is exposed to an oxidation catalyst which oxidizes the methane through contact therewith. Then, the resultant gas is fed again to the heat exchanger for heat recovery through heat exchange with un-reacted gas. Further, the flow rate of gas to be treated is varied, according to a concentration of the methane contained in this treated gas. | 2012-07-26 |
20120189524 | BARIUM FLUOROBORATE, NONLINEAR OPTICAL CRYSTAL OF BARIUM FLUOROBORATE, PREPARATION METHOD AND USE THEREOF - The present invention provides a barium fluoroborate compound, a nonlinear optical crystal and the preparation method and use thereof. Both of the barium fluoroborate compound and the nonlinear optical crystal have a chemical formula of Ba | 2012-07-26 |
20120189525 | Contamination Free Compression of Corrosive Gas - A process for the synthesis of a high purity corrosive gas generated by decomposition of a precursor solid at high temperature deploys a dry vacuum pump and a compressor in series so that the corrosive gas is pressured as it fills storage containers. | 2012-07-26 |
20120189526 | PROCESS AND PLANT FOR PREPARING TRICHLOROSILANE - A process for preparing trichlorosilane includes reacting silicon particles with tetrachlorosilane and hydrogen and optionally with hydrogen chloride in a fluidized-bed reactor to form a trichlorosilane-containing product gas stream, where the trichlorosilane-containing product gas stream is discharged from the reactor via an outlet preceded by at least one particle separator which selectively allows only silicon particles up to a particular maximum size to pass through and silicon particles are discharged from the reactor at preferably regular intervals or continuously via at least one further outlet without such a particle separator. | 2012-07-26 |
20120189527 | PRODUCTION OF POLYCRYSTALLINE SILICON IN SUBSTANTIALLY CLOSED-LOOP PROCESSES THAT INVOLVE DISPROPORTIONATION OPERATIONS - Production of polycrystalline silicon in substantially closed-loop processes and systems is disclosed. The processes and systems generally involve disproportionation of trichlorosilane to produce silane or dichlorosilane and thermal decomposition of silane or dichlorosilane to produce polycrystalline silicon. | 2012-07-26 |
20120189528 | PROCESS AND APPARATUS FOR RECOVERING AMMONIA FROM A GAS STREAM - The present invention relates to a process for the recovery of ammonia contained in a gaseous stream, said process comprising the following phases: (a) subjecting the gaseous stream containing ammonia to a washing with an aqueous washing solution having a pH lower than 7.0, with the formation of a purified gaseous stream and an aqueous solution containing an ammonium salt; (b) treating the aqueous solution containing the ammonium salt coming from phase (a) in a vertical falling film heat exchanger at a temperature from 50 to 250° C. and an absolute pressure ranging from 50 KPa to 4 MPa with the formation of a regenerated washing solution and a gaseous stream comprising NH | 2012-07-26 |
20120189529 | CARBON DIOXIDE GAS PROCESSING APPARATUS AND CARBON DIOXIDE GAS PROCESSING METHOD - Disclosed is a carbon dioxide gas processing apparatus including an oxidization vessel for producing a magnesium oxide by oxidizing magnesium-containing powder in an atmosphere of a gas such as a carbon dioxide gas that contains oxygen as a constituent element thereof, a carbonate production tank that reserves water or a water solution therein and that introduces the magnesium containing oxygen as a constituent element produced in the oxidization vessel, and a carbon dioxide gas supplying means for supplying carbon dioxide gas to the carbonate production tank. | 2012-07-26 |
20120189530 | System And Process For Producing Hydrogen And A Carbon Nanotube Product - A system for producing hydrogen and a carbon nanoproduct includes a hydrocarbon feed gas supply configured to supply a hydrocarbon feed gas at a selected flow rate, a reactor having a hollow reactor cylinder with an enclosed inlet adapted to continuously receive the hydrocarbon feed gas, a reaction chamber in fluid communication with the inlet, and an enclosed outlet in fluid communication with the reaction chamber adapted to discharge a product gas comprised of hydrogen and unreacted hydrocarbon feed gas, along with the carbon nanoproduct. The system also includes a catalyst transport system adapted to move a selected amount of a metal catalyst through the reaction chamber at a rate dependent on the flow rate of the hydrocarbon feed gas to form the product gas. The system also includes a carbon separator adapted to separate the carbon product from the product gas and from the metal catalyst. | 2012-07-26 |
20120189531 | METHOD FOR MAKING A CHALCOPYRITE-TYPE COMPOUND - A method for making a chalcopyrite-type compound includes: reacting a reaction mixture in a first solvent under reflux condition to form the chalcopyrite-type compound containing M | 2012-07-26 |
20120189532 | COLLOIDAL NANOPARTICLE MATERIALS FOR PHOTODETECTORS AND PHOTOVOLTAICS - A composite material is described. The composite material comprises semiconductor nanocrystals, and organic molecules that passivate the surfaces of the semiconductor nanocrystals. One or more properties of the organic molecules facilitate the transfer of charge between the semiconductor nanocrystals. A semiconductor material is described that comprises p-type semiconductor material including semiconductor nanocrystals. At least one property of the semiconductor material results in a mobility of electrons in the semiconductor material being greater than or equal to a mobility of holes. A semiconductor material is described that comprises n-type semiconductor material including semiconductor nanocrystals. At least one property of the semiconductor material results in a mobility of holes in the semiconductor material being greater than or equal to a mobility of electrons. | 2012-07-26 |
20120189533 | METHOD FOR MAKING A CHALCOPYRITE-TYPE COMPOUND - A method for making a chalcopyrite-type compound includes reacting a reaction mixture in a solvent under reflux condition to form the chalcopyrite-type compound. The reaction mixture includes at least one first compound and at least one second compound. The first compound contains M | 2012-07-26 |
20120189534 | Method of manufacture of silver oxide nano particles - Manufacture of silver oxide nano particles is disclosed comprising using Armine-z as desegregating agent for silver salt solution and precipitating it with sodium hydroxide. | 2012-07-26 |
20120189535 | Controlling Morpholoy of Titanium Oxide Using Designed Peptides - A method for biomimetically preparing titanium oxide precipitates with specific morphologies. According to one embodiment, designed peptides that are 5-20 amino acids long are used as initiators to cause the precipitation of titanium oxide from a buffered aqueous solution containing a titanium oxide precursor, such as titanium(IV) bis(ammonium lactate) dihydroxide. The peptides consist of amino acids that are hydrophilic at neutral pH, such as serine, and amino acids that are cationic at neutral pH, such as lysine and arginine. The peptides sequences are designed to induce the formation of specific morphologies including, but not limited to, spheres, rectangular blocks, cubes, porous sheets, non-porous sheets, and flowers. The method enables the formation of distinct and consistent titanium oxide morphologies without a need for high temperatures and pressures or for caustic reaction conditions. This, in turn, allows for oxide formation in the presence of environmentally sensitive materials and limits hazardous waste streams. | 2012-07-26 |
20120189536 | PEROVSKITE-TYPE STRONTIUM TITANATE - The present invention relates to a perovskite-type strontium titanate, wherein the strontium titanate is Y- and Ni-doped and has the general formula (Sr,Y)(Ti,Ni)O | 2012-07-26 |
20120189537 | NITRILE DERIVATIVES AND THEIR PHARMACEUTICAL USE AND COMPOSITIONS - Disclosed are nitrile derivatives and pharmaceutical compositions comprising nitrile derivatives. The pharmaceutical compositions comprise compounds of the formula I | 2012-07-26 |
20120189538 | USE OF A2A ADENOSINE RECEPTOR AGONISTS - Myocardial imaging methods that are accomplished by administering doses of a pharmaceutical composition including regadenoson—an adenosine A | 2012-07-26 |
20120189539 | BCL-2/BCL-XL INHIBITORS AND THERAPEUTIC METHODS USING THE SAME - Inhibitors of Bcl-2/Bcl-xL and compositions containing the same are disclosed. Methods of using the Bcl-2/Bcl-xL inhibitors in the treatment of diseases and conditions wherein inhibition of Bcl-2/Bcl-xL provides a benefit, like cancers, also are disclosed. | 2012-07-26 |
20120189540 | IL3Ralpha Antibody Conjugates And Uses Thereof - The present invention provides antibodies that bind to the IL-3 receptor alpha subunit alpha (Il3Rα) chain, and compositions comprising such antibodies. The present invention provides methods for inhibiting or reducing an IL3Rα-expressing cell population, the methods comprising contacting a population of IL3Rα-expressing cells (e.g., cancer cells and/or cancer stem cells) with an antibody that binds to IL3Rα. The present invention also provides antibody conjugates comprising an antibody that binds to an IL3Rα chain linked to a cytotoxic agent or anticellular agent and compositions comprising such conjugates. The present invention also provides methods for preventing, treating and/or managing a disorder associated with IL3Rα-expressing cells (e.g., a hematological cancer), the methods comprising administering to a subject in need thereof an antibody that binds to IL3Rα. | 2012-07-26 |
20120189541 | Dual Variable Domain Immunnoglobulins and Uses Thereof - The present invention relates to engineered multivalent and multispecific binding proteins, methods of making, and specifically to their uses in the prevention, diagnosis, and/or treatment of disease. | 2012-07-26 |
20120189542 | Anti-CD19 Antibodies - The present invention provides humanized, chimeric and human anti-CD19 antibodies, anti-CD19 antibody fusion proteins, and fragments thereof that bind to a human B cell marker. Such antibodies, fusion proteins and fragments thereof are useful for the treatment and diagnosis of various B-cell disorders, including B-cell malignancies and autoimmune diseases. In more particular embodiments, the humanized anti-CD19 antibodies may comprise one or more framework region amino acid substitutions designed to improve protein stability, antibody binding and/or expression levels. In a particularly preferred embodiment, the substitutions comprise a Ser91Phe substitution in the hA19 VH sequence. | 2012-07-26 |
20120189543 | Compositions and Methods for Detecting and Treating Implant Loosening and Osteolysis - Methods and compositions for detecting, diagnosing, and treating osteolysis and implant loosening are disclosed. | 2012-07-26 |
20120189544 | GASTROINTESTINAL DISEASE OR DISORDER IMAGING AND TREATMENT - The disclosure provides methods for detection, prognosis and diagnosis of gastrointestinal polyps, cancer diseases and disorders. | 2012-07-26 |
20120189545 | ISOTOPICALLY-LABELED BENZOFURAN COMPOUNDS AS IMAGING AGENTS FOR AMYLOIDOGENIC PROTEINS - Benzofuran compounds which contain at least one detectable label selected from the group consisting of | 2012-07-26 |
20120189546 | Radiolabelling Method Using Cycloalkyl Groups - This invention relates to novel cyclo alkyl compounds suitable for labeling by | 2012-07-26 |
20120189547 | [18F] LABELLED ANALOGUES OF FLUMAZENIL AS IN VIVO IMAGING AGENTS - The present invention provides radiofluorinated compounds useful for in vivo imaging GABA | 2012-07-26 |
20120189548 | 2-ARYLPYRAZOLO[L,5-ALPHA]PYRIMIDIN-3-YL ACETAMIDE DERIVATIVES AS LIGANDS FOR TRANSLOCATOR PROTEIN (18 KDA) - The invention provides compounds of formula (I) radiolabelled with | 2012-07-26 |
20120189549 | DEVICE FOR AUTOMATING BEHAVIORAL EXPERIMENTS ON ANIMALS - The present invention enables testing the effect of one or more test agent(s) on one or more animal(s) of a group of animals, preferably insects, to identify agents that affect behavioral properties of the animals. The invention is comprised of the steps of providing animals suitable for testing, bringing those animals into contact with the test agent(s), moving the animals from a growth container to isolate them, prepare and separate the animals for singulation, relocated the animals to a behavior arena, subject the animals to behavioral tracking to assess their behavioral state, and removing the animals from the behavioral tracking to facilitate iterative analysis of further groups. The invention enables a method for preparing a therapeutic compound for the treatment of an animal disease. | 2012-07-26 |
20120189550 | ORALLY ADMINISTERED BACTERIA AS VEHICLES FOR SYSTEMATIC DELIVERY OF AGENTS - The current invention relates to the use of a bacterial species in the preparation of a composition adapted for oral administration for the delivery of an agent to a site in the body. The site in the body may be an organ or a tumour site. The bacterial species is a food grade, non-pathogenic, gram-positive bacteria capable of anaerobic growth. | 2012-07-26 |
20120189551 | MRI Markers, Delivery and Extraction Systems, and Methods of Manufacture and Use Thereof - Novel, non-toxic cobalt-based contrast and imaging agents for use in enhanced medical imaging modalities and processes are described, as well the manufacture of markers containing such contrast agents is described, and uses for such imaging markers and contrast agents in a variety of therapeutic applications and devices. | 2012-07-26 |
20120189552 | COMPOSITIONS AND METHODS USING MICROSPHERES AND NON-IONIC CONTRAST AGENTS - The present invention relates to compositions and methods for treating diseases and disorders including cancer and various other angiogenic-dependent diseases, vascular malfunctions, arteriovenous malformations (AVM), hemorrhagic processes and treatment of pain, in particular tumor-related pain by drug delivery and/or therapeutic embolization using microspheres. More particularly the invention relates to microspheres containing non-ionic contrast agents, to compositions comprising these microspheres, as well as methods for preparing and using such compositions for embolization therapy. The invention further relates to compositions and methods using detectable microspheres for targeted drug delivery, irrespective of whether embolization is also needed. | 2012-07-26 |
20120189553 | Dental cleaning composition for evidencing dental plaque - The present invention relates to oral compositions for identifying plaque comprising a dental disclosing agent composition for revealing the presence of dental plaque in a person's mouth. The dental disclosing agent composition includes natural colorants derived from a red beet extract, a pomegranate concentrate, and one or more of lycopene, red beet powder extract, and purple carrot extract powder, and a dental disclosing agent delivery composition for delivering the dental disclosing agent to a person's mouth. | 2012-07-26 |
20120189554 | MULTI-FUNCTIONAL DRUG CARRIERS - Various biodegradable polyglutamate-amino acids comprising recurring units of the general formulae (I) and (II) are prepared. Such polymers are useful for variety of drug, targeting, stabilizing and/or imaging agent delivery applications. | 2012-07-26 |
20120189555 | METHODS AND COMPOSITIONS FOR PREVENTION OR TREATMENT OF RSV INFECTION - Methods and compositions are provided for the prevention or treatment of RSV infection in a human. The methods include administering one or more doses of a composition comprising an siRNA. The dose can be formulated for topical or parenteral administration. Topical administration includes administration as a nasal spray, or by inhalation of respirable particles or droplets. The siRNA comprises a sense strand of ALN-RSV01 and an antisense strand of ALN-RSV01. | 2012-07-26 |
20120189556 | PHARMACEUTICAL COMPOSITIONS BASED ON ANTICHOLINERGICS AND CORTICOSTEROIDS - A pharmaceutical composition comprising an anticholinergic and a steroid, optionally together with a pharmaceutically acceptable excipient, the anticholinergic and the steroid optionally in the form of their enantiomers, mixtures of their enantiomers, their racemates, their solvates, or their hydrates, processes for preparing them, and their use in the treatment of respiratory tract diseases. | 2012-07-26 |
20120189557 | Topical Delivery with a Carrier Fluid - Aerosol spray formulations capable of delivering high concentrations of active agent-containing materials and/or excipient are described herein. The formulation contains a carrier fluid, a propellant and a therapeutic, prophylactic, cosmeticeutical and/or inert solid suspended, dissolved, or dispersed in the formulation. The active ingredient may be an antibiotic, an antihistamine, an anesthetic, an anti-inflammatory, and/or an astringent. In one embodiment, the active agent is an antifungal agent. In another embodiment, the active agent is a cosmeticeutical. The active agent can optionally be dispersed on, or associated with, a carrier powder. The carrier fluid is a highly volatile silicone liquid, which evaporates in less than | 2012-07-26 |
20120189558 | ANTI-BACTERIAL COMPOSITIONS COMPRISING EXTRACTS OF EREMOPHILA LONGIFOLIA AND METHODS FOR USE OF SAME - A method for inhibiting growth of bacteria is provided wherein the method comprises the step of administering to a region in need of bacterial growth inhibition an anti-bacterially effective amount of a composition comprising an extract from the plant | 2012-07-26 |
20120189559 | Carrageenan Products and Method for Their Production and Use - The present invention is directed to a carrageenan product comprising a semi-refined, alkali treated iota carrageenan wherein the semi-refined, alkali treated iota carrageenan has: (i) a viscosity of 18 cP to 83 cP, (ii) a particle size of at least 90% passing through a #100 US sieve mesh and at least 20% passing through a #230 US sieve mesh, and (iii) a fraction of sodium cations of at least 35%, wherein the fraction of sodium cations is determined by the weight of sodium cations divided by the sum of the weight of sodium cations and potassium cations. This invention is also directed to toothpaste compositions comprising the carrageenan product of the invention. | 2012-07-26 |
20120189560 | Sugar-free Beverage Composition - A beverage composition for strengthening and protecting tooth structure from decay and cavities, and for promoting dental health is provided. The beverage composition comprises one or more of about 0.5% to about 5% by weight of a polyol, about 0.005% to about 25% by weight of a natural and/or an artificial sweetener, about 1% to about 30% by weight of one or more vitamins and minerals, and their derivatives, a soluble source of fluoride ions containing about 0.1 ppm to about 1 ppm of fluoride ions, about 0.002% to about 0.008% of a water soluble casein, predetermined quantities of an herbal and/or fruit extract, a licorice root extract obtained, for example, from Glycyrrhiza uralensis, a non-mineral nutritional supplement, a flavoring agent, a preservative, a coloring agent, and a sufficient amount of a base composition, for example, water. The pH of the beverage composition is about 3.5 to about 7.0. | 2012-07-26 |
20120189561 | Toothpaste Composition - The present invention is directed to a toothpaste composition comprising a binder, an abrasive, a foaming agent, water, and polyethylene glycol, wherein the binder comprises semi-refined carrageenan. The toothpaste composition has improved shelf life. | 2012-07-26 |
20120189562 | USE OF PHOTOLUMINESCENT POLYMERS IN COSMETIC PRODUCTS - Disclosed are cosmetic compositions and methods for making up keratinous tissue using the compositions, as well as methods of making the compositions. The compositions contain a photoluminescent polymer (PLP) which is an oligomeric polyester synthesized from a multifunctional monomer and a diol, and which has grafted thereon an amino acid or an amino acid derivative. The compositions achieve a colorizing and/or UV-protectant effect when applied to keratinous tissue. | 2012-07-26 |
20120189563 | ORAL COMPOSITION FOR ALLEVIATING ULTRAVIOLET IRRADIATION-INDUCED DAMAGE - Disclosed are: an oral composition for alleviating ultraviolet irradiation-induced damage, which can be used on a daily basis and is stable and safe; and a medicinal agent; and anti-wrinkle agent and a food composition, each of which comprises the oral composition. Specifically disclosed is an oral composition for alleviating ultraviolet irradiation-induced damage, which comprises at least one compound selected from the group consisting of methionine and derivatives and/or salts thereof. The composition may be an anti-wrinkle agent, a pharmaceutical composition for treating and/or preventing skin diseases, a food composition, or a pharmaceutical composition for preventing or treating cataract. In the oral composition for alleviating ultraviolet irradiation-induced damage, methionine may be in the D-form. | 2012-07-26 |
20120189564 | COMPOSITIONS OF VITAMIN C DERIVATIVE AND PORTULACA EXTRACT - Compositions including Portulaca extract and a vitamin C derivative selected from ascorbyl glucoside (ASG), magnesium ascorbyl phosphate an ethyl ascorbic acid. The compositions can be employed as an inhibitor to melanin formation and used as an additive to a cosmetic or pharmaceutical formulation. | 2012-07-26 |
20120189565 | SKIN CLARIFYING COMPLEX, USE OF SAID COMPLEX, COSMESTIC OR PHARMACEUTICAL COMPOSITION COMPRISING SAID COMPLEX AND METHOD FOR APPLICATION THEREOF - It is disclosed a skin clarifying complex comprising gallic acid and linoleic acid. It is further provided that the gallic acid can be obtained from | 2012-07-26 |
20120189566 | EXTERNAL PREPARATION CONTAINING PANTETHINE PHOSPHATE ESTER - A pantethine phosphate ester represented by the following formula (1) or formula (2) exhibits superior tyrosinase inhibitory effect and melanin production inhibitory effect. | 2012-07-26 |
20120189567 | Artemisinin Derivatives with Natural Amino Acids, Peptides, and Amino Sugars for Skin Imperfections and Infection in Mammals - The present invention discloses certain derivatives of artemisinin and the active principles contained in | 2012-07-26 |
20120189568 | ANTIMICROBIAL AMINO-SALICYLIC ACID DERIVATIVES - Disclosed is a novel method for achieving an antimicrobial, preservative and/or microorganism adhesion inhibiting effect, for the protection within an article and/or material or on the surface of an article and/or material. The novel method comprises application of a salicylic compound of the formula (I) wherein one of A and A is a residue of the formula (I′): —NH—CO—R | 2012-07-26 |
20120189569 | Hydroxy Acid Complexes for Skin Renovation and Clarity - This invention relates to complexes of certain divalent and polyvalent d-orbital metals of first transition series of the Periodic Table of Elements, from Group IV to Group VI, and including molybdenum, having a hydroxy acid [HA] and an amino acid [AA] moiety concurrently bound to a single said metal and having a spirocyclic, bidentate chelate structure of formula (I). Upon topical application said metal complexes undergo enhanced skin penetration without causing skin irritation. The said metal complexes are useful for topical conditions that includes dry skin, xerosis, ichthyosis, dandruff, brownish spots, keratoses, melasma, lentigines, age spots, dark circles around eyes, skin pigmentation, topical inflammation, liver spots, pigmented spots, wrinkles, blemishes, skin lines, oily skin, acne, warts, eczema, pruritic skin, psoriasis, inflammatory dermatoses, disturbed keratinization, dandruff, bacterial infection, fungal infection, wound healing, body odor, and skin changes associated with aging; | 2012-07-26 |
20120189570 | HAIR TREATMENT AGENTS COMPRISING SURFACTANT(S) AND PROTEOLIPID(S) - The present invention is a hair treatment agent comprising at least one surfactant and at least one proteolipid of the formula R′—X—R″, wherein R′ is a straight-chain or branched, saturated or unsaturated hydrocarbon radical having 11 to 24 carbon atoms; R″ is a protein, a peptide, or a protein hydrolyzate; X is —C(O)O—, —N | 2012-07-26 |
20120189571 | NANOSCALE PLATINUM COMPOUNDS AND METHODS OF USE THEREOF - The invention is directed to biocompatible conjugated polymer nanoparticles including a copolymer backbone, a plurality of sidechains covalently linked to said backbone, and a plurality of platinum compounds dissociably linked to said backbone. The invention is also directed to dicarbonyl-lipid compounds wherein a platinum compound is dissociably linked to the dicarbonyl compound. The invention is also directed to methods of treating cancer or metastasis. The methods includes selecting a subject in need of treatment for cancer or metastasis and administering to the subject an effective amount of any of the nanoparticles, compounds, or compositions of the invention. | 2012-07-26 |
20120189572 | VACCINES TARGETING CELLULAR DEATH RECEPTORS - The invention provides therapeutics and methods to induce a mammalian host, including a human, to produce antibodies, which agonize death receptors and cause the apoptotic death of target cells within the host's body. The therapeutics are vaccine compositions, including genetic vaccines encoding death receptor antigens of the tumor necrosis factor receptor family. Also provided are means and methods for overcoming host immunological tolerance to death receptors. The vaccines are useful against cancer cells and other death receptor bearing target cells within the host, and can be used in both therapeutic and prophylactic settings. The vaccines are also useful for diagnostic testing of the immunocompetence of a host. | 2012-07-26 |
20120189573 | Methods of using death receptor agonists and EGFR inhibitors - Methods for using death receptor ligands, such as Apo-2 ligand/TRAIL polypeptides or death receptor antibodies, and EGFR inhibitors to treat pathological conditions such as cancer are provided. Embodiments of the invention include methods of using Apo2L/TRAIL or death receptor antibodies such as DR5 antibodies and DR4 antibodies in combination with EGFR inhibitors, such as Tarceva™. | 2012-07-26 |
20120189574 | METHODS FOR HEMATOPOIETIC PRECURSOR MOBILIZATION - Methods of modulating mobilization of cells from the bone marrow are provided. In a specific embodiment there is provided a method of increasing mobilization of hematopoietic precursors from the bone marrow to the peripheral blood in a subject in need thereof, the method comprising: (a) administering to the subject an agent which downregulates an activity or expression of a coagulation factor or an effector thereof; and (b) harvesting the hematopoietic precursors from the peripheral blood. | 2012-07-26 |
20120189575 | Oligodendrocyte Production from Multipotent Neural Stem Cells - This invention relates to methods of producing oligodendrocytes from multipotent neural stem cells by using at least one oligodendrocyte promoting factor, particularly granulocyte-macrophage colony stimulating factor, granulocyte colony stimulating factor, interleukin 3 or interleukin 5. The neural stem cells may optionally be expanded prior to being subjected to the oligodendrocyte promoting factor. | 2012-07-26 |
20120189576 | 3'-[(2Z)-[1-(3,4-DIMETHYLPHENYL)-1,5-DIHYDRO-3-METHYL-5-OXO-4H-PYRAZOL-4-Y- LIDENE]HYDRAZINO]-2'-HYDROXY-[1,1'-BIPHENYL]-3-CARBOXYLIC ACID bis-(MONOETHANOLAMINE) - An improved thrombopoietin mimetic, the bis-(monoethanolamine) salt of 3′-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2′-hydroxy-[1,1′-biphenyl]-3-carboxylic acid. | 2012-07-26 |
20120189577 | USE OF IL-12 TO INCREASE SURVIVAL FOLLOWING ACUTE EXPOSURE TO IONIZING RADIATION - The present invention is directed to methods of increasing survival following exposure to non-therapeutic radiation comprising administration of IL-12. | 2012-07-26 |
20120189578 | COMPOSITIONS AND METHODS FOR POTENTIATING INTERLEUKIN-35 - Compositions and methods are provided for potentiating activity of interleukin-35 (IL-35). Such compositions and methods include administering therapeutically effective amounts of non-blocking IL-35 binding agents. The non-blocking IL-35 binding agents do not block the binding of IL-35 to its target(s). Also provided are methods to identify non-blocking IL-35 binding agents that enhance IL-35 activity. | 2012-07-26 |
20120189579 | SUBSTITUTED PYRROLIDINONE AS INHIBITORS OF HEPATITIS C NS5B POLYMERASE, THE PHARMACEUTICAL COMPOSITION THEREOF AND THEIR THERAPEUTIC USE - The present invention concerns a substituted pyrrolidinone of the following formula I or a salt, solvate, tautomer, isotope, enantiomer, diastereoisomer or racemic mixture thereof: (I), for the treatment of hepatitis C. | 2012-07-26 |
20120189580 | ANTI-INFECTIVE AGENTS AND USES THEREOF - This invention relates to: (a) compounds and salts thereof that, inter alia, inhibit HCV; (b) intermediates useful for the preparation of such compounds and salts; (c) compositions comprising such compounds and salts; (d) methods for preparing such intermediates, compounds, salts, and compositions; (e) methods of use of such compounds, salts, and compositions; and (f) kits comprising such compounds, salts, and compositions. | 2012-07-26 |
20120189581 | USE OF TOXOPLASMA AND DERIVED COMPOSITIONS TO PREVENT OR TREAT MICROBIAL INFECTIONS - The invention provides a composition comprising an amount of a live attenuated or avirulent | 2012-07-26 |
20120189582 | SIMIAN ADENOVIRUS 41 AND USES THEREOF - Novel simian adenovirus 41 and two isolates thereof are described. Various uses of these isolates, including construction of a recombinant vector which comprises simian adenovirus 41 sequences and a heterologous gene under the control of regulatory sequences are provided. A cell line which expresses simian adenovirus 41 gene(s) is also disclosed. Methods of using the vectors and cell lines are provided. | 2012-07-26 |
20120189583 | PLACENTAL OR UMBILICAL CORD TISSUE COMPOSITIONS - The present invention encompasses compositions, including solutions, gels, and pastes, manufactured from amniotic membrane, umbilical cord membrane, or both. The present invention also encompasses methods of making such compositions, and methods of using the compositions to treat conditions of the eye. | 2012-07-26 |
20120189584 | GENIPIN CROSS-LINKED FIBRIN GELS - The invention provides a genipin cross-linked fibrin gel. The ratio of genipin to fibrin in the gel ranges from about 0.1:1 to about 10:1 (genipin:fibrin). The gel can be hydrogel. Also provided is method for repairing tissue defects by administering the gel to site of tissue defect. | 2012-07-26 |
20120189585 | METHOD AND COMPOSITION FOR RESTORATION OF AGE-RELATED TISSUE LOSS IN THE FACE OR SELECTED AREAS OF THE BODY - This application relates to stem cell compositions and methods for restoring age-related tissue loss in the face and other selected areas of the body. In a first embodiment, a composition includes stem cells and hyaluronic acid as a carrier wherein the stem cells are peripheral blood stem cells, bone marrow-derived blood stem cells, or mesenchymal stem cells. | 2012-07-26 |
20120189586 | Human Placental Derived Extracellular Matrix and Uses Therof - The invention provides a composition for use in tissue augmentation of a human. More specifically, the composition comprises collagen extracted from human placenta and a bulking agent. Furthermore, the invention discloses methods of augmenting soft tissue comprising the use of the compositions described herein. | 2012-07-26 |
20120189587 | CELL SHEET FOR TISSUE REPAIR AND BIO-ARTIFICIAL TISSUE ENGINEERING, METHOD OF PRODUCING THE SAME AND METHOD OF USING THE SAME - Disclosed is a cell sheet for tissue repair and bio-artificial tissue engineering. The cell sheet comprises treated stem cell embedded in its self-secreted extracellular matrix (ECM) and formed a cell sheet. The cell sheet is formed by isolating the stem cell, expanding the stem cell and treating the stem cell with biological factors or factors leading to the production of biological factors, to induce its differentiation, production of extracellular matrix and formation of a cell sheet in vitro. The cell sheet is used as a bioactive material or as an acellular material for the promotion of tissue repairs or used to form a bio-artificial organ for tissue replacement. The cell sheet of the present invention eliminates the need to use scaffolds for cell delivery. The cell sheet facilitates in vivo cell transplantation and provides some tensile mechanical strength for bearing early mechanical load during tissue repair. | 2012-07-26 |
20120189588 | Compositions and Methods for Implantation of Processed Adipose Tissue and Processed Adipose Tissue Products - The invention provides compositions and methods for the preparation of processed adipose tissue. The invention further provides methods of use of the processed adipose tissue. | 2012-07-26 |
20120189589 | COMPOSITIONS AND IMPROVED SOFT TISSUE REPLACEMENT METHODS - The specification discloses compositions and methods for treating a soft tissue defect of an individual. | 2012-07-26 |